IHC markers are complementary tools beneficial for confirming viral-induced carcinogenesis, highlighting EBV presence in RCC by double testing: nested PCR and IHC assay for expression of p53, p16INK4a, Ki-67 and NF-κB. Here, TP53 is linked to renal cell carcinoma.